Ten persistent myths and the realities of membrane bioreactor technology for municipal applications

Twelve years after the first full scale municipal application in Europe of membrane bioreactor (MBR) technology, the process is now accepted as a technology of choice for wastewater treatment, and the market is showing sustained growth. However early misconceptions about the technology are persistent and false statements are commonly encountered in articles and conferences, generating unnecessary research efforts or even fuelling either fascination or scepticism with regards to the technology, which is ultimately detrimental to the perception of the process by water professionals. We try to provide some factual and rational clarifications on ten issues which are often wrongly reported about MBR technology.

Long-term comparison of trace organics removal performances between conventional and membrane activated sludge processes

The removal of trace organic compounds through membrane bioreactors (MBR) compared with a conventional wastewater treatment plant (WWTP) in a long-term study was investigated. Two MBR pilot plants were operated in parallel to a full-scale WWTP fed with the same municipal raw wastewater. Polar compounds (phenazone-type pharmaceuticals, their metabolites, and carbamazepine) and less polar estrogenic steroids (estradiol, estrone, and ethinylestradiol) were quantified. The removal rate of phenazone, propyphenazone, and formylaminoantipyrine by the conventional WWTP was less than 15%. Significantly higher removal rates (60 to 70%) started to be clearly monitored in the pilot plants after approximately 5 months. Higher removal rates coincided with higher temperatures in the summer. The conventional WWTP removed, on average, more than 90% of the natural steroids estrone and estradiol and approximately 80% of the synthetic ethinylestradiol. Approximately 99% of estradiol and estrone and approximately 95% of ethinylestradiol was eliminated by the MBR processes.

[Generalized granuloma annulare: remission during treatment of HIV infection]

INTRODUCTION

Granuloma annulare is a benign dermatosis characterized by pale or erythematous papules grouped in rings or in arch form figures. We report the observation combining a granuloma annulare and a Human Immunodeficiency Virus (HIV) infection, with regression of the granuloma annulare on initiation of treatment of the HIV infection.

OBSERVATION

A 33 year-old man presented with an eruption of multiple, erythematous papules predominating on the trunk and limbs but sparing the face. Histology confirmed the diagnosis of generalized granuloma annulare. We diagnosed an HIV infection. Remission of the granuloma annulare was obtained concomitantly when immune restoration was obtained following the prescription of an antiretroviral tritherapy.

DISCUSSION

Since 1985, several cases of atypical forms of granuloma annulare have been reported in HIV-infected patients. Nevertheless, the precise relationship between the two diseases is unknown. The case we report on raises the question of the relationship between granuloma annulare and immunodepression.

Outcomes of a 2-year investigation on enhanced biological nutrients removal and trace organics elimination in membrane bioreactor (MBR)

Two configurations of membrane bioreactors were identified to achieve enhanced biological phosphorus and nitrogen removal, and assessed over more than two years with two parallel pilot plants of 2m3 each. Both configurations included an anaerobic zone ahead of the biological reactor, and differed by the position of the anoxic zone: standard pre-denitrification, or post-denitrification without dosing of carbon source. Both configurations achieved improved phosphorus removal. The goal of 50 microgP/L in the effluent could be consistently achieved with two types of municipal wastewater, the second site requiring a low dose of ferric salt ferric salt < 3 mgFe/L. The full potential of biological phosphorus removal could be demonstrated during phosphate spiking trials, where up to 1 mg of phosphorus was biologically eliminated for 10 mg BOD5 in the influent. The post-denitrification configuration enabled a very good elimination of nitrogen. Daily nitrate concentration as low as 1 mgN/L could be monitored in the effluent in some periods. The denitrification rates, greater than those expected for endogenous denitrification, could be accounted for by the use of the glycogene pool, internally stored by the denitrifying microorganisms in the anaerobic zone. Pharmaceuticals residues and steroids were regularly monitored on the two parallel MBR pilot plants during the length of the trials, and compared with the performance of the Berlin-Ruhleben WWTP. Although some compounds such as carbamazepine were persistent through all the systems, most of the compounds could be better removed by the MBR plants. The influence of temperature, sludge age and compound concentration could be shown, as well as the significance of biological mechanisms in the removal of trace organic compounds.

Cost effective and advanced phosphorus removal in membrane bioreactors for a decentralised wastewater technology

Future stringent phosphorus regulations (down to 50 microg/L in some cases) together with the availability of more cost effective and/or innovative membrane processes, are the bases for this project. In contrast to conventional activated sludge plants, process parameters are not optimised and especially enhanced biological phosphorus (Bio-P) removal in membrane bioreactors (MBRs) are not proven yet. Current practice of P-removal in MBRs is the addition of coagulants in a co-precipitation mode. Enhanced biological phosphorus removal, when adapted to MBR technology, might be a cost-effective process. For very stringent effluent criteria additional P-adsorption on activated clay after membrane filtration can be also an interesting solution. The objective of this research project is to identify and test various phosphorus removal processes or process combinations, including MBR technologies. This should enable us to establish efficient and cost effective P-removal strategies for upgrading small sewage treatment units (up to 10,000 PE), as needed in some decentralised areas of Berlin. In particular, enhanced Bio-P removal technology was developed and optimised in MBR. Combinations of co-precipitation and post-adsorption will be tested when low P-values down to 50 microg/L are required in the effluent. One MBR bench-scale plant of 200 to 250 L and two MBR pilot plants of 1 to 3 m3 each were operated in parallel to a conventional wastewater treatment plant (Ruhleben WWTP, Berlin, Germany). The MBR bench-scale and pilot plants were operated under sludge ages of respectively 15 and 25 days. In both cases, Bio-P was possible, and phosphorus effluent concentration of about 0.1 mg/L could be achieved. A similar effluent quality was observed with the conventional WWTP. Investigations with lab columns indicated that P-adsorption could lead to concentrations down to 50 microg/L and no particle accumulation occurred in the filter media. The three tested materials exhibited great differences in break-through curves. Granulated ferric hydroxyde (GEH) showed higher capacity than activated alumina and FerroSorpPlus.

Hanced biological phosphorus removal in membrane bioreactors

Enhanced biological phosphorus removal (Bio-P) in a membrane bioreactor (MBR) promises several advantages but was never attempted as not compatible with high sludge ages. This article includes description and results of bench-scale investigations on Bio-P removal in an MBR. An MBR bench-scale plant (210 L) was operated in parallel to a conventional WWTP under comparable process conditions. The results show that Bio-P removal is possible in MBR. The effluent qualities of the plants were comparable. The effluent P-concentration was always lower than 0.2 mg P(T)/L. In the MBR bench-scale plant P-uptake occurred mainly in the anoxic zone. Investigations with P-spiking showed higher Bio-P potential as P-removal increased up to 20-25 mg/L while P/TS rose up to >6%.